Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.

[1]  P. Noble,et al.  Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis. , 2016, Annual Review of Medicine.

[2]  J. Roman,et al.  Studying human respiratory disease in animals – role of induced and naturally occurring models , 2016, The Journal of pathology.

[3]  W. Kuebler,et al.  Identification and Validation of Larixyl Acetate as a Potent TRPC6 Inhibitor , 2016, Molecular Pharmacology.

[4]  N. Kaminski,et al.  FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis. , 2015, American journal of respiratory and critical care medicine.

[5]  E. White Lung extracellular matrix and fibroblast function. , 2015, Annals of the American Thoracic Society.

[6]  M. Königshoff,et al.  Live and let die: targeting alveolar epithelial cell proliferation in pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.

[7]  B. Southern,et al.  TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. , 2014, The Journal of clinical investigation.

[8]  Jill R. Johnson,et al.  Pericytes in Chronic Lung Disease , 2014, International Archives of Allergy and Immunology.

[9]  C. Shimbori,et al.  Fibrocytes in pulmonary fibrosis: a brief synopsis , 2013, European Respiratory Review.

[10]  W. Altemeier,et al.  Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.

[11]  H. Alsaid,et al.  An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure , 2012, Science Translational Medicine.

[12]  L. Birnbaumer,et al.  A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. , 2012, Developmental cell.

[13]  B. Hinz,et al.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. , 2012, The American journal of pathology.

[14]  W. Kuebler,et al.  Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. , 2012, Cell calcium.

[15]  T. Gudermann,et al.  Activation of TRPC6 channels is essential for lung ischaemia–reperfusion induced oedema in mice , 2012, Nature Communications.

[16]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[17]  T. Blackwell,et al.  Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress* , 2011, The Journal of Biological Chemistry.

[18]  S. Nathan,et al.  Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.

[19]  Sanjay Kumar,et al.  From Molecular Signal Activation to Locomotion: An Integrated, Multiscale Analysis of Cell Motility on Defined Matrices , 2011, PloS one.

[20]  B. Nilius,et al.  The transient receptor potential family of ion channels , 2011, Genome Biology.

[21]  B. Hinz,et al.  The myofibroblast: paradigm for a mechanically active cell. , 2010, Journal of biomechanics.

[22]  M. Burdick,et al.  The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis , 2009, Journal of leukocyte biology.

[23]  L. Farkas,et al.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. , 2009, The Journal of clinical investigation.

[24]  W. Liedtke Molecular Mechanisms of TRPV4‐Mediated Neural Signaling , 2008, Annals of the New York Academy of Sciences.

[25]  C. Hogaboam,et al.  Murine models of pulmonary fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[26]  R. Chambers,et al.  Molecular targets in pulmonary fibrosis: the myofibroblast in focus. , 2007, Chest.

[27]  W. Seeger,et al.  The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. , 2007, American journal of respiratory cell and molecular biology.

[28]  B. Hinz Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[29]  T. Gudermann,et al.  Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange , 2006, Proceedings of the National Academy of Sciences.

[30]  D. Sheppard,et al.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.

[31]  T. Gudermann,et al.  Increased Vascular Smooth Muscle Contractility in TRPC6−/− Mice , 2005, Molecular and Cellular Biology.

[32]  C. Speer,et al.  Impact of Basic Research on Tomorrow's MedicineThe Role of Transforming Growth Factor β in Lung Development and Disease , 2004 .

[33]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[34]  H. Watanabe,et al.  Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Kodaira,et al.  Impaired Pressure Sensation in Mice Lacking TRPV4* , 2003, Journal of Biological Chemistry.

[36]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[37]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[38]  G. Schultz,et al.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity , 2000, Nature Cell Biology.

[39]  Y. Mori,et al.  Molecular and Functional Characterization of a Novel Mouse Transient Receptor Potential Protein Homologue TRP7 , 1999, The Journal of Biological Chemistry.

[40]  T. Gudermann,et al.  Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol , 1999, Nature.

[41]  P. Hiemstra,et al.  Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .

[42]  R. Chambers,et al.  Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats. , 1998, American journal of respiratory cell and molecular biology.

[43]  R. Hurst,et al.  Cloning and Expression of a Novel Mammalian Homolog ofDrosophila Transient Receptor Potential (Trp) Involved in Calcium Entry Secondary to Activation of Receptors Coupled by the Gq Class of G Protein* , 1997, The Journal of Biological Chemistry.

[44]  G. Laurent,et al.  Application of high-pressure liquid chromatography to studies of collagen production by isolated cells in culture. , 1990, Analytical biochemistry.

[45]  R. McAnulty Fibroblasts and myofibroblasts: their source, function and role in disease. , 2007, The international journal of biochemistry & cell biology.

[46]  Oliver Eickelberg,et al.  Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD. , 2014, American journal of physiology. Lung cellular and molecular physiology.